KalVista Pharmaceuticals (KALV) FCF Margin (2014 - 2025)
KalVista Pharmaceuticals (KALV) reported FCF Margin of 109.58% for Q3 2025, up 70.26% sequentially from 368.52% in Q2 2025.
KalVista Pharmaceuticals (KALV) FCF Margin (2014 - 2025) Analysis & Trends
KalVista Pharmaceuticals (KALV) has 8 years of FCF Margin data on file, last reported at 109.58% in Q3 2025.
- For the quarter ending Q3 2025, FCF Margin changed N/A year-over-year to 109.58%; the trailing twelve-month figure through Jul 2025 stood at 208.31% (up 89480.0% YoY), and the FY2025 full-year result was 1394.01%, down 121546.0% from the prior year.
- FCF Margin climbed to 109.58% in Q3 2025, from 368.52% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 109.58% in Q3 2025 to a low of 368.52% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | -109.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -109.58% |
| Apr 30, 2025 | -368.52% |
| Apr 30, 2020 | -330.18% |
| Jan 31, 2020 | -831.26% |
| Oct 31, 2019 | -202.24% |
| Jul 31, 2019 | -337.58% |
| Apr 30, 2019 | -368.63% |
| Jan 31, 2019 | -279.59% |
| Oct 31, 2018 | -161.07% |
| Jul 31, 2018 | -182.28% |
| Apr 30, 2018 | -145.43% |
| Jan 31, 2018 | 1,202.83% |
| Oct 31, 2017 | -648.62% |
| Jul 31, 2017 | -4,747.92% |
| Apr 30, 2017 | -2,322.81% |
| Jan 31, 2017 | -4,535.08% |
| Oct 31, 2016 | -2,134.01% |
| Jul 31, 2016 | -584.31% |
| Mar 31, 2016 | -71,785.71% |
| Dec 31, 2015 | -78,600.00% |